The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2017
Made: 6th May 2017
Coming into force: 31st May 2017
To be laid before Parliament: 13th June 2017
The Secretary of State, in exercise of the powers conferred by sections 7(4) and 7(5) of the Misuse of Drugs Act 1971[^f00001], and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, makes the following Order:
Citation, commencement and extent
1
- (1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2017 and comes into force on 31st May 2017.
- (2) This Order extends to England and Wales and Scotland.
Amendment to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015
2
- (1) The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015[^f00002] is amended as follows.
- (2) In paragraph 1(a) of Part 1 of the Schedule—
- (a) before “Bufotenine” insert—
- Adinazolam (1-(8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine)
- N-Benzyl-ethylphenidate
- Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
- (b) after “Cathinone” insert—
- 4’-Chlorodiazepam(7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- Clonazolam(6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)
- (c) after “Concentrate of poppy-straw” insert—
- Deschloroetizolam(2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)
- 3,4-Dichloroethylphenidate
- 3,4-Dichloromethylphenidate (3,4-DCMP)
- Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- Ethylnaphthidate
- Ethylphenidate
- (d) after “Eticyclidine” insert—
- Etizolam
- (e) after “Etryptamine” insert—
- Flubromazepam (7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- Flubromazolam(8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)
- 4-Fluoroethylphenidate
- 4-Fluoromethylphenidate
- Fonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- (f) after “Gamma-butyrolactone” insert—
- 3-Hydroxyphenazepam(7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- Isopropylphenidate (IPP or IPPD)
- (g) after “Lysergide and otherN-alkyl derivatives of lysergamide” insert—
- Meclonazepam(5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- (h) after “Methcathinone” insert—
- 4-Methylmethylphenidate
- Methylmorphenate
- Methylnaphthidate (HDMP-28)
- Metizolam(4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)
- Nifoxipam (5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
- Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
- Propylphenidate
- (i) after “Psilocin” insert—
- Pyrazolam(8-Bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)
- (j) after “3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)” insert—
- 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700)
Signed
Sarah Newton — Parliamentary Under Secretary of State — Home Office — 6th May 2017
Explanatory note
(This note is not part of the Order)
EXPLANATORY NOTE
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (S.I. 2015/704) by inserting a synthetic opioid (U-47,700), several methylphenidate related materials and a number of designer benzodiazepines into Part 1 of the Schedule to that Order.
An impact assessment will be published alongside the Explanatory Memorandum on the legislation.gov.uk website.
Footnotes
[^f00001]: 1971 c. 38.
[^f00002]: S.I. 2015/704 as amended by S.I. 2016/1124.
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.